Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Sun Pharmaceutical is currently trading at Rs. 517.30, up by 4.90 points or 0.96% from its previous closing of Rs. 512.40 on the BSE.
The scrip opened at Rs. 518.80 and has touched a high and low of Rs. 523.00 and Rs. 516.40 respectively. So far 5,129 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 539.90 on 05-Dec-2011 and a 52 week low of Rs. 392.05 on 09-Feb-2011.
Last one week high and low of the scrip stood at Rs. 539.90 and Rs. 505.50 respectively. The current market cap of the company is Rs. 53,569.00 crore.
The promoters holding in the company stood at 63.72% while Institutions and Non-Institutions held 25.48% and 10.81% respectively.
Sun Pharmaceutical Industries’ subsidiary has been granted an approval from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market a generic version of Ultram ER, Tramadol hydrochloride extended release tablets.
These generic Tramadol hydrochloride extended release tablets, 100 mg, 200 mg and 300 mg are therapeutically equivalent to Ultram ER tablets of Valeant. These Tramadol HCL ER tablets have annual sales of approximately $125 million in US.
Tramadol HCL ER tablets are indicated for management of moderate to moderately severe chronic pain in adults who need around-the-clock treatment of their pain for an extended period of time.
Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1464.85 |
| Dr. Reddys Lab | 5955.65 |
| Cipla | 1477.15 |
| Zydus Lifesciences | 1050.35 |
| Lupin | 1603.55 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
